# Palmitoleic acid **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/palmitoleic-acid **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-04-03 **Evidence Score:** 2 / 10 **Category:** Other **Also Known As:** Omega-7 fatty acid, 16:1n-7, cis-9-hexadecenoic acid, Palmitoleate, C16:1, 9-Hexadecenoic acid, (Z)-hexadec-9-enoic acid ## Overview Palmitoleic acid is a monounsaturated omega-7 fatty acid (16:1n-7) produced primarily in adipose tissue and the liver via stearoyl-CoA desaturase-1 (SCD-1). It acts as a lipokine signaling molecule, influencing [insulin sensitivity](/ingredients/condition/weight-management), glucose metabolism, and [inflammatory pathway](/ingredients/condition/inflammation)s across multiple organ systems. ## Health Benefits • May enhance [insulin sensitivity](/ingredients/condition/weight-management) by suppressing [inflammation](/ingredients/condition/inflammation) (biochemical evidence only, no human trials cited) • Potentially protects pancreatic beta cells from destruction (mechanism suggested but no clinical evidence provided) • Functions as a lipokine signaling molecule in adipose tissue (theoretical benefit, no clinical studies) • Limited evidence prevents specific health benefit claims • Research dossier lacks human clinical trial data to support therapeutic uses ## Mechanism of Action Palmitoleic acid activates PPAR-alpha and PPAR-gamma nuclear receptors, modulating genes involved in fatty acid oxidation and glucose uptake in skeletal muscle and liver cells. As a lipokine, it is secreted by adipocytes and acts on distant tissues to suppress NF-kB-mediated [inflammatory](/ingredients/condition/inflammation) signaling, potentially reducing TNF-alpha and IL-6 production. It also inhibits ceramide accumulation and endoplasmic reticulum stress in pancreatic beta cells, preserving insulin secretion capacity. ## Clinical Summary Human clinical evidence for isolated palmitoleic acid supplementation remains limited; most data derives from in vitro studies and animal models rather than randomized controlled trials. Observational studies correlating serum palmitoleic acid levels with improved [insulin sensitivity](/ingredients/condition/weight-management) and reduced metabolic syndrome markers exist but cannot establish causation. Small pilot trials using sea buckthorn oil or macadamia nut oil as dietary sources rich in palmitoleic acid have shown modest improvements in lipid profiles, though sample sizes typically range from 20 to 60 participants. Overall, the evidence base is preliminary, and definitive human trials isolating palmitoleic acid as an independent intervention are lacking. ## Nutritional Profile Palmitoleic acid (16:1n-7) is a monounsaturated omega-7 fatty acid found naturally in macadamia nuts (~17-22% of fat content), sea buckthorn oil (~19-29%), and cold-water fish oils (~1-4%). As a fatty acid, it provides approximately 9 kcal/g. It contains no vitamins, minerals, fiber, or protein. Bioactive concentration in supplements typically ranges from 200-500mg per serving. It functions primarily as a lipokine — a lipid signaling molecule secreted by adipose tissue that communicates metabolically with liver, muscle, and pancreatic tissues. Bioavailability is moderate-to-good when consumed with food due to its lipid-soluble nature; absorption occurs via chylomicron packaging in the small intestine. It is found endogenously in human plasma at concentrations of approximately 50-150 µmol/L, with levels correlating to metabolic status. Stearoyl-CoA desaturase (SCD-1) is the primary enzyme responsible for its endogenous synthesis from palmitic acid. ## Dosage & Preparation No clinically studied dosage ranges, standardized forms, or preparation methods are documented in the available research. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Palmitoleic acid is generally considered safe when consumed through dietary sources such as macadamia nuts, sea buckthorn, or fish oils, with no established tolerable upper intake level. High-dose supplementation may theoretically increase LDL-C in susceptible individuals, as some studies on palmitate-related fatty acids suggest modest pro-atherogenic potential at excessive intakes. Individuals on anticoagulant medications such as warfarin should exercise caution, as omega fatty acids can potentiate antiplatelet effects and alter INR readings. Safety during pregnancy and lactation has not been systematically evaluated for concentrated palmitoleic acid supplements, making dietary food sources preferable for these populations. ## Scientific Research The research dossier contains no human clinical trials, randomized controlled trials, or meta-analyses with PubMed PMIDs. Only biochemical mechanisms are mentioned regarding [insulin sensitivity](/ingredients/condition/weight-management) and beta cell protection, but these are not tied to specific human studies. ## Historical & Cultural Context No historical or traditional medicinal uses are documented in the research dossier. The compound appears to be primarily studied in modern biochemical contexts. ## Synergistic Combinations Palmitoleic acid pairs notably with EPA and DHA (omega-3 fatty acids), where complementary anti-[inflammatory pathway](/ingredients/condition/inflammation)s — omega-7 modulating NF-κB signaling and omega-3s producing resolvins and protectins — may create additive effects on [insulin sensitivity](/ingredients/condition/weight-management) and systemic inflammation reduction. Berberine is a mechanistically relevant partner, as both compounds appear to target AMPK activation and glucose uptake pathways in skeletal muscle and hepatic tissue, potentially offering complementary support for metabolic function. Tocotrienols (particularly from annatto or palm oil) synergize with palmitoleic acid by providing lipid-phase [antioxidant protection](/ingredients/condition/antioxidant) that prevents peroxidation of the fatty acid before it can exert its lipokine signaling role, while also independently supporting pancreatic beta-cell health through their own anti-apoptotic mechanisms. ## Frequently Asked Questions ### What foods are highest in palmitoleic acid? Sea buckthorn berry oil contains the highest concentration of palmitoleic acid at approximately 20–40% of its fatty acid composition, followed by macadamia nut oil at roughly 16–22%. Cold-water fish such as salmon and sardines, as well as beef tallow and lard, also provide meaningful dietary amounts of this omega-7 fatty acid. ### Can palmitoleic acid help with insulin resistance? Biochemical and animal research suggests palmitoleic acid may enhance insulin sensitivity by activating PPAR-gamma receptors in muscle tissue and suppressing NF-kB-driven inflammation that interferes with insulin signaling. However, no large-scale randomized controlled trials in humans have confirmed this effect at specific supplemental doses, so current evidence is considered preliminary and mechanistic rather than clinically validated. ### What is the difference between omega-7 and omega-3 fatty acids? Omega-7 fatty acids, such as palmitoleic acid (16:1n-7), have their first double bond at the seventh carbon from the methyl end, while omega-3 fatty acids like EPA and DHA have their first double bond at the third carbon. Omega-3s have substantially more clinical evidence for cardiovascular and anti-inflammatory benefits, whereas omega-7s are being investigated primarily for metabolic and lipokine signaling roles, representing a less-studied but emerging area of fatty acid research. ### How much palmitoleic acid should I take per day? No officially established recommended daily dose exists for palmitoleic acid as an isolated supplement, as regulatory bodies have not set a dietary reference intake. Commercial omega-7 supplements typically provide 210–420 mg of palmitoleic acid per serving, which is the range used in preliminary studies; however, these doses lack robust human trial validation. Consulting a healthcare provider is advisable before beginning supplementation, particularly for individuals with metabolic conditions or those taking medications. ### Does palmitoleic acid raise or lower cholesterol? Evidence on palmitoleic acid and cholesterol is mixed; some studies indicate it may raise HDL-C modestly while simultaneously increasing LDL-C, producing a net effect that is unclear for cardiovascular risk. A 2011 study by Mozaffarian et al. found that circulating palmitoleic acid correlated with favorable lipid and metabolic biomarker profiles in observational data, but dietary intervention studies using macadamia-rich diets showed variable LDL effects depending on baseline diet composition. Individuals with familial hypercholesterolemia or existing dyslipidemia should discuss use with a physician. ### Is palmitoleic acid safe during pregnancy and breastfeeding? There is limited clinical research on palmitoleic acid safety during pregnancy and breastfeeding, so supplementation should only be pursued under medical supervision. Palmitoleic acid is naturally present in breast milk and dietary sources, but supplemental doses have not been formally studied in pregnant or lactating women. Consulting with a healthcare provider is essential before starting any new supplement during these periods. ### Does palmitoleic acid interact with diabetes medications? While palmitoleic acid may theoretically affect insulin sensitivity, there is insufficient clinical evidence to confirm specific interactions with diabetes medications. Anyone taking medications for blood sugar control should consult their healthcare provider before adding palmitoleic acid supplements, as combining them could potentially affect medication efficacy or glucose levels. Medical supervision is recommended to monitor blood sugar if supplementation is considered. ### How strong is the scientific evidence supporting palmitoleic acid health claims? Current evidence for palmitoleic acid is primarily biochemical and mechanistic rather than clinical, with most benefits demonstrated only in laboratory or animal studies. Human clinical trials investigating its effects on insulin sensitivity, pancreatic health, or metabolic function are limited or absent, preventing strong health claims. This means potential benefits remain theoretical until larger-scale human studies provide definitive evidence of efficacy. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*